Concepedia

Oussama ElMokh

OE

5

Publications

96

Citations

5

H-Index

2017

Active since

Affiliations

University of Bern(Current)

Peter MacCallum Cancer Centre

University of Lausanne

University of Genoa

Oussama ElMokh is an author at University of Bern specializing in apoptosis, medicine, and cell death.

Top concepts

Publications per year

2017–2022

5

Publications

5

Combined MEK and Pi3′-kinase inhibition reveals synergy in targeting thyroid cancer <i>in vitro</i> and <i>in vivo</i>

Oussama ElMokh, Dorothée Ruffieux-Daidié, Matthias A. Roelli et al. · Oncotarget · 2017 · 25 citations · Full text

PIK3CAH1047R-induced paradoxical ERK activation results in resistance to BRAFV600E specific inhibitors in BRAFV600E PIK3CAH1047R double mutant thyroid tumors

Matthias A. Roelli, Dorothée Ruffieux-Daidié, Amandine Stooss et al. · Oncotarget · 2017 · 24 citations · Full text

Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent

Anne-Julie Cloux, Dominique Aubry, Mathieu Heulot et al. · Oncotarget · 2019 · 22 citations · Full text

, , +16

Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia

Oussama ElMokh, Saki Matsumoto, Paulina Biniecka et al. · Cell Death and Disease · 2022 · 15 citations · Full text

MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid Cancer

Oussama ElMokh, Vincent Taelman, Piotr Radojewski et al. · Journal of Nuclear Medicine · 2018 · 10 citations · Full text

Rows per page

1–5 of 5